Raia Drogasil (BSP:RADL3) Other Long-Term Liabilities: R$177 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:RADL3 Raia Drogasil SA BSP:RADL3
95 GF Score
Price R$19.99
GF Value R$27.40
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Raia Drogasil Other Long-Term Liabilities?

Raia Drogasil BSP:RADL3 -1.38% 95 Other Long-Term Liabilities is R$177 Mil as of Jun. 2026. GuruFocus rates BSP:RADL3 with a GF Score™ of 95/100 and a GF Value™ of R$27.40 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Raia Drogasil's other long-term liabilities for the quarter that ended in Jun. 2026 was R$177 Mil.

Raia Drogasil's quarterly other long-term liabilities declined from Dec. 2025 (R$320 Mil) to Mar. 2026 (R$210 Mil) and declined from Mar. 2026 (R$210 Mil) to Jun. 2026 (R$177 Mil).

Raia Drogasil's annual other long-term liabilities declined from Dec. 2023 (R$382 Mil) to Dec. 2024 (R$378 Mil) and declined from Dec. 2024 (R$378 Mil) to Dec. 2025 (R$320 Mil).

Raia Drogasil Other Long-Term Liabilities Related Terms

Raia Drogasil Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Raia Drogasil's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Raia Drogasil Other Long-Term Liabilities Chart

Raia Drogasil Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 257.45 238.23 382.22 378.02 320.31

Raia Drogasil Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 348.03 301.20 320.31 209.58 177.06
BSP:RADL3
95GF Score
Raia Drogasil SA BSP:RADL3
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Raia Drogasil Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of R$177 Mil mean?
Raia Drogasil (BSP:RADL3) has a Other Long-Term Liabilities of R$177 Mil as of Jun. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Raia Drogasil and its competitors.
Is Raia Drogasil's Other Long-Term Liabilities too high?
Raia Drogasil's current Other Long-Term Liabilities is R$177 Mil. Overall, Raia Drogasil has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Raia Drogasil's Other Long-Term Liabilities compare to competitors?
Raia Drogasil's Other Long-Term Liabilities of R$177 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Healthcare Providers & Services company?
A good Other Long-Term Liabilities depends on the Healthcare Providers & Services industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Raia Drogasil and its competitors. Raia Drogasil's current Other Long-Term Liabilities is R$177 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raia Drogasil stock overvalued right now?
Based on GuruFocus' analysis, Raia Drogasil (BSP:RADL3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$27.40, compared to a current price of R$19.99 — trading 27% below its estimated fair value. The current Other Long-Term Liabilities is R$177 Mil. Raia Drogasil's overall GF Score™ is 95/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Raia Drogasil (BSP:RADL3), the current Other Long-Term Liabilities is R$177 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Raia Drogasil (BSP:RADL3) Overvalued in 2026?

Based on GuruFocus' analysis, Raia Drogasil stock appears to be undervalued. The current stock price of R$19.99 is trading 27% below its estimated GF Value™ of R$27.40. GuruFocus considers Raia Drogasil to be Modestly Undervalued.

Key valuation signals for BSP:RADL3:

  • Other Long-Term Liabilities: R$177 Mil
  • GF Value™: R$27.40 vs. price of R$19.99 (27% below fair value)
  • GF Score™: 95/100 with 2 warning signs

No single metric tells the full story. See the BSP:RADL3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Raia Drogasil Business Description

Other Exchanges RADLY:USA
Address Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-900
Raia Drogasil SA operates a chain of pharmacies in Brazil. The company is mainly engaged in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines. Its pharmacies mainly operate under the Drogasil and Raia brands.
95GF Score

Get the complete analysis for BSP:RADL3

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$19.99
Price
R$27.40
GF Value